How to Run an Annual Product Portfolio Review with a Gantt Chart

An annual product portfolio review is one of the most strategically important exercises a product or business leadership team can run—and one of the most frequently performed badly. Without a structured process, portfolio reviews become subjective debates where the loudest voice determines which products get investment, and the data never gets assembled in time for the decisions to be evidence-based.

A Gantt chart for product portfolio review keeps the process on a timeline, ensures data is gathered before decisions are made, and coordinates the cross-functional team through analysis, decision, and implementation.

This guide maps the complete portfolio review process using a free Gantt chart at gantt-chart.io.

Why Product Portfolio Reviews Need a Structured Timeline

Product portfolio reviews fail for predictable reasons:

Data isn't ready when decisions need to be made — financial data, customer data, and technical assessments all come from different systems and teams; without a data-gathering phase with a hard deadline, the review meeting starts without full information
Decisions don't stick — without a formal decision process, "portfolio review" becomes a discussion rather than a commitment; nothing changes
Implementation never happens — EOL decisions, pricing changes, and R&D reallocations require cross-functional coordination that doesn't happen automatically after a leadership meeting
The review is annual in name only — without a defined start date and timeline, the review slips and becomes 14-month or 18-month cycles

A Gantt chart solves all four failure modes by making the review a project with phases, owners, and deadlines.

Phase 1: Data Gathering (Weeks 1–4)

No analysis can happen before the data is assembled. This phase runs across four workstreams simultaneously—financial, customer, competitive, and technical.

Financial data (Product finance + BI team):

Revenue by SKU or product line for the trailing 12 months and 3-year trend
Gross margin by product line (ideally contribution margin after variable costs)
Revenue growth rate vs. prior year and vs. market growth rate
Customer acquisition cost (CAC) and lifetime value (LTV) by product line where separable
R&D spend allocated to each product line
Customer support cost attributed to each product line

Customer data (Customer success + product analytics):

Net Promoter Score (NPS) by product line
Churn rate by product line for the past 12 months
Feature adoption rates for key product capabilities
Qualitative feedback themes from customer interviews and support tickets segmented by product
Customer concentration risk: for each product line, what % of revenue comes from the top 5 customers?

Competitive data (Product strategy + marketing):

Competitive position for each product line: market leader, fast follower, or laggard?
Competitive win/loss rates where tracked
Pricing position relative to competitive set: premium, parity, or discount?
Notable competitive moves in the past 12 months that affect each product line's position

Technical data (Engineering + architecture):

Technical debt assessment for each product line (low/medium/high/critical)
Maintenance cost estimate for each product line at current state
Integration complexity: which products are tightly coupled to others, making EOL decisions non-trivial?
Security and compliance vulnerability exposure by product

Milestone: Data gathering complete; all inputs delivered to product strategy team

Phase 2: Product Line P&L Analysis (Weeks 4–5)

With raw data assembled, the product strategy team constructs a one-page P&L summary for each product line. This is the foundation of all subsequent analysis.

For each product line, build a summary view:

Metric	Value	Trend (YoY)
Revenue (trailing 12 mo)
Gross Margin %
Revenue Growth Rate
NPS
Churn Rate
R&D Investment (trailing 12 mo)
R&D Investment (planned next 12 mo)
Technical Debt Score
Competitive Position

This view allows direct comparison across the portfolio on a common set of dimensions.

Phase 3: BCG Matrix and Strategic Positioning (Week 5–6)

Plot each product line on two classic frameworks to generate strategic insight:

BCG Growth-Share Matrix:

Horizontal axis: Relative market share (your share vs. largest competitor)
Vertical axis: Market growth rate
Quadrants: Stars (high share, high growth), Cash Cows (high share, low growth), Question Marks (low share, high growth), Dogs (low share, low growth)

Strategic fit assessment:

For each product line, assess fit against the company's stated 3-year strategy:

Core — central to the company's identity and future; must be protected and invested
Adjacent — not core today but strategically valuable if scaled; worth selective investment
Non-core — generates revenue but doesn't advance the strategy; manage for cash or divest

The combination of BCG position and strategic fit drives the investment prioritization in Phase 5.

Phase 4: EOL and Sunset Decisions (Weeks 6–7)

This is the most emotionally charged phase of the portfolio review—and the most valuable one if done well.

Products meeting EOL criteria (any three of the following):

Revenue declining at >15% per year for two consecutive years
Gross margin below 20% with no credible path to improvement
NPS in the bottom quartile of the portfolio
Competitive position: laggard, with no differentiated capability
Technical debt: critical, requiring more investment to maintain than the product generates
Strategic fit: non-core, with no path to becoming adjacent or core

EOL decision process:

Product strategy presents EOL candidates with supporting data
Leadership team reviews and challenges assumptions (requires data, not sentiment)
For products with significant customer concentration, assess customer retention risk if the product is sunset
Formal EOL decision recorded in meeting minutes with: product name, EOL date, customer communication plan, support wind-down timeline, resource reallocation target

Milestone: EOL decisions formally approved by executive leadership

Phase 5: Investment Priority Ranking (Week 7–8)

With EOL decisions made, the remaining portfolio is ranked by investment priority.

Investment priority criteria:

Strategic fit score (core = 3, adjacent = 2, non-core = 1)
Growth rate (above market = 3, at market = 2, below market = 1)
Margin profile (above target = 3, at target = 2, below target = 1)
Competitive position (leader = 3, fast follower = 2, laggard = 1)
Technical health (low debt = 3, medium = 2, high = 1)

Sum the scores. The resulting ranked list guides R&D budget reallocation from EOL products to high-priority growth products.

Phase 6: Resource Reallocation Planning (Weeks 8–9)

R&D reallocation — Reassign engineering capacity freed by EOL decisions to the top 2–3 investment-priority products; update headcount plans and project roadmaps accordingly
Marketing reallocation — Shift demand generation budget from end-of-life and non-core products to growth products
Go-to-market adjustments — Update sales compensation plans, partner program terms, and pricing for investment-priority products to reflect new strategic importance
Pricing review — For cash cow products, assess whether pricing power supports margin expansion without further R&D investment

Phase 7: Board and Executive Presentation (Weeks 9–10)

Portfolio summary slide — Visual portfolio map (BCG matrix or bubble chart with revenue as bubble size) showing the full portfolio position
EOL decision summary — Products being sunset, rationale, timeline, and expected impact on revenue and margin
Investment priority ranking — Top products receiving increased R&D and marketing investment; expected outcomes
Resource reallocation summary — Where freed capacity is going and expected return timeline
Risk register — Key risks from portfolio decisions: customer retention risk from EOL products, competitive response risk from investment decisions, execution risk for R&D reallocation

Phase 8: Implementation Tracking (Weeks 10–16)

Portfolio review decisions mean nothing without implementation. Add implementation milestones to the Gantt chart to track execution.

Pricing changes — Effective date; responsible owner: product or finance
EOL customer communication — Communication sent; support end date communicated; migration path offered
R&D team transitions — Engineers reassigned from EOL to growth products; sprint planning updated
Annual brand health review — Schedule the next portfolio review 12 months out; assign a data-gathering owner to ensure this year's missing data is captured continuously

Building Your Portfolio Review Gantt Chart

Open gantt-chart.io — free, no account needed
Create rows for each phase and workstream: Financial Data, Customer Data, Competitive Data, Technical Data, P&L Analysis, BCG Mapping, EOL Decisions, Investment Ranking, Reallocation, Board Prep, Implementation
Set 10-week project duration with milestones at data completion, EOL decisions, and board presentation
Share with product, finance, engineering, and marketing leads
Lock the annual cadence: start the next review 9 months after the current one closes

A product portfolio review run on a Gantt chart is a managed, evidence-based process—not an annual leadership debate.